The SynapCore Platform
Upload a standard clinical EEG recording. SynapCore preprocesses the signal, extracts spectral and connectivity features, and returns a structured report with probability scores, confidence intervals, and feature importance. Five condition-specific modules, one unified pipeline.
Shared EEG Pipeline
All five modules share the same preprocessing and feature extraction pipeline. Only the classification model is module-specific, trained on condition-relevant biomarkers.
Shared Pipeline
Module-Specific Classifiers
Five Conditions. One Platform.
All modules are currently in research and development. Neuraxis is the most advanced, with validated research results.
Neuraxis
ADHDResearch PhaseAUC 0.845 (paediatric) · AUC 0.727 (adult)
EEG-based attention and hyperactivity biomarker analysis for ADHD diagnostic support. Most advanced module with validated research results across paediatric and adult populations using LOSO cross-validation.
Lumia Neuro
DepressionIn DevelopmentNeural connectivity pattern analysis supporting major depressive disorder assessment through frontal alpha asymmetry and coherence metrics.
PsycheVox
SchizophreniaIn DevelopmentSpectral and connectivity analysis for schizophrenia spectrum disorder evaluation using gamma band and auditory ERP markers.
Equinox
Bipolar DisorderIn DevelopmentEEG biomarker profiling for bipolar disorder state differentiation using resting-state power spectral density analysis.
Serenex
PTSDIn DevelopmentTrauma-related neural pattern recognition for PTSD clinical decision support using theta oscillation and hyperarousal markers.
Interested in SynapCore?
Whether you are a researcher, clinician, or investor, we welcome conversations about the future of EEG-based diagnostics.
All SynapCore modules are currently in research and development phase and are not approved for clinical diagnostic use. Research Use Only (RUO).